User:Rrivera0717/drholmestemp

Dennis R. Holmes, M.D. is an American Board of Surgery certified surgeon specializing in the treatment of breast cancer. He is a graduate of Tulane University School of Medicine, the University of California, San Francisco-East Bay Surgical Residency, and the University of Southern California Breast Surgery Fellowship Program. Dr. Holmes sees patients at the Harold E. & Henrietta C. Lee Breast Center at the University of Southern California Norris Comprehensive Cancer Center and Hospital where he works closely with medical oncologists, radiation oncologists, radiologists, plastic surgeons, genetic counselors, and gynecologists to provide comprehensive, personalized, breast cancer care.

Dr. Holmes practices Oncoplastic breast surgery and minimally invasive breast surgery. Oncoplastic breast surgery combines sound cancer surgery principles with plastic surgery techniques to achieve complete tumor removal, obtain wider surgical margins, and minimize the risk of recurrence while still providing the best possible cosmetic results. Minimally invasive breast surgery is a form of breast surgery where tumors are removed through smaller incisions placed under the breast and in the underarm area, thereby reducing the need for scars on the breast. Immediate or delayed reconstruction is available if a mastectomy is performed.

Education
Dr. Holmes graduated from McDonogh No. 35 Senior High School in New Orleans, Louisiana in 1983. He then attended Loyola University New Orleans studying biology and graduating Summa Cum Laude in 1987. In 1991 he graduated from Tulane University School of Medicine with his doctorate degree. After his graduation from medical school, he completed an internship in General surgery at theWashington University School of Medicine Barnes–Jewish Hospital from 1991 to 1992. In 1993 Dr. Holmes started his Residency in general surgery at the same institution. He later left to finish his Residency at the University of California, San Francisco-East Bay beginning in 1999 and culminating in 2002. Dr. Holmes joined the Keck School of Medicine of USC the following year to complete his fellowship in Breast Cancer.

Academic Appointments

 * Assistant Professor of Clinical Surgery, USC Keck School of Medicine, Los Angeles, CA (2003-Present)

Clinical Administrative Appointments

 * Chief, Breast Section, LAC+USC Medical Center, Los Angeles, CA (2003-Present).

Specific Teaching Responsibilities

 * Lecturer, USC Keck School of Medicine, Medical Student Surgery Clerkship, Breast Skills Workshop, & Bedside Tutorials (2003-Present).
 * Faculty, USC Breast Fellowship Program, Los Angeles, CA (2003-Present).
 * Lecturer, USC Keck School of Medicine, Medical Oncology Fellowship Program (2003-Present).
 * Lecturer, USC Keck School of Medicine, Radiation Oncology Fellowship Program (2003-Present).
 * Instructor, School of Oncoplastic Surgery, American Society of Breast Diseases (2007-2008).
 * Instructor, Minimally Invasive Breast Biopsy Clinic, LAC+USC Medical Center (2003-2006).

Specific Administrative Responsibilities

 * Director and Faculty, USC Breast Fellowship Program Los Angeles, CA, (2007-2010).
 * Associate Director and Faculty, USC Breast Fellowship Program Los Angeles, CA (2003-2007).
 * Clinical Investigations Committee Member, USC Norris Comprehensive Cancer Center, Los Angeles, CA (2007-Present).
 * Chair, Multidisciplinary Breast Conference, LAC + USC Medical Center, Los Angeles, CA (2007-Present).
 * Member, Women’s Cancer Program, USC Norris Comprehensive Cancer Center, Los Angeles, CA (2009-present).
 * Member, Breast Leadership Team, USC Norris Comprehensive Cancer Center, Los Angeles, CA (2009-Present).
 * Vice-Chair, Breast Oncology Clinical Research Committee, USC Norris Comprehensive Cancer Center,Los Angeles, CA (January 2010-Present).

Symposia

 * 1) American Society of Breast Diseases, 34rd Annual Symposium,Program Committee, Session Chair,Dallas, Texas. March 24-26, 2011
 * 2) American Society of Breast Diseases, 33rd Annual Symposium, Program Committee, Presenter: Interdisciplinary Tumor Board, Presenter: Intraoperative Radiotherapy of the Breast,Chicago, IL. April 2-4, 2009
 * 3) American Society of Breast Surgeons, 9th Annual Meeting, Presenter: Interdisciplinary Tumor Board, Faculty: Invasive Disease: Staging and Treatment, New York, NY. April 30-May 4, 2008
 * 4) American Society of Breast Diseases, 31ST Annual Symposium, Program Committee. Faculty: Invasive Disease: Staging and Treatment, San Diego, CA. April 12-14, 2007

Sessions Chaired

 * 1) American Society of Breast Diseases, “Best Breast Cancer Papers in the World Literature” New York City, NY. April 17, 2010
 * 2) American Society of Breast Surgeons, 11th Annual Meeting Partial Breast Radiation Workshop, Co-Chaired with Peter Beitsch, Las Vegas, NV. April 30, 2010
 * 3) American Society of Breast Surgeons, 10th Annual Meeting, General Session-Management Issues/Controversy, San Diego, CA. April 26, 2009
 * 4) Southern California Chapter of the American College of Surgeons, Annual Meeting, Presiding Officer: Breast Paper Session, Santa Barbara, CA. January 16, 2009
 * 5) American Society of Breast Diseases, 33rd Annual Symposium, Program Committee, Chair: Treatment of High Risk Lesions, Session Co-Chair: Minimally Invasive Surgery in an Interdisciplinary Setting, Chicago, IL. April 2-4 2009
 * 6) Society of Surgical Oncology, 2007 Annual Meeting, Moderator: Breast Poster Session, Washington, DC.	March 15-18 2009

National Organizations

 * TARGIT Steering Committee, National Co-chair (2010-Present)
 * American Society of Breast Diseases, Board-of-Director, Communications Committee (2009-2010)
 * National Consortium of Breast Centers, Communications Committee (2006–2007)

Local Organizations

 * Charles R. Drew Medical Society, Board Member (2007-Present)
 * Charles R. Drew Medical Society, Chair-Clinical Trial Committee (2007-Present)

University/Other Organizations

 * Admissions Committee, USC Keck School of Medicine (2009-Present)
 * Division Chief’s Committee, LAC+USC Medical Center (2008-Present)
 * Medical Executive Committee, LAC+USC Medical Center, (2008-Present)
 * Medical Student Applicant Interview Committee, USC Keck School of Medicine (2006-Present)
 * Residency Interview Committee, USC Keck School of Medicine, Department of Surgery (2003-Present)
 * Resident Mock Oral Examination Committee, USC Keck School of Medicine, Department of Surgery (2003-2007, 2010)
 * Organizing Committee, Salerni Collegium Annual Tennis Tournament. USC Keck School of Medicine (2005-2007)
 * Faculty Advisor, MedGLO (Gay and Lesbian Medical Student   Organization, USC Keck School of Medicine (2008-Present)

Honors and Awards
Church of the Nazarene, Los Angeles, CA
 * 2009 “Strong Voice Award” for Breast Cancer Advocacy, Denise Roberts Breast Cancer Foundation, Los Angeles, CA
 * 2007 County of Los Angeles Outstanding Community Service Award, Los Angeles Board of Supervisors, Los Angeles, CA
 * 2007 “Spirit of Excellence Award” My Sister-My Friend Breast Cancer Support Group, Los Angeles, CA
 * 2007 Community Achievement Award, Women of Color Breast Cancer Survivors Support Project, Los Angeles, CA
 * 2007 Community Achievement Award, Breast Cancer Awareness Day

Memberships and Affiliations

 * Society of Black Academic Surgeons (2010-Present)
 * International Society of Surgery, Breast Surgery International (2009-Present)
 * American Society of Clinical Oncology (2009-Present)
 * American College of Surgeons, Fellow (2003-Present)
 * Society of Surgical Oncology (2004-Present)
 * American Society of Breast Surgeons (2002-Present)
 * American Society of Breast Disease (2007-Present)
 * American College of Surgeons Oncology Group (2004-Present)
 * Southern California Chapter American College of Surgeons (2003-Present)
 * Los Angeles Surgical Society (2003-Present)

International

 * 1) Intraoperative Radiotherapy for the Management of Early Stage Breast Cancer. Kameda Medical Center, Kamogawa, Japan,  September 2, 2009
 * 2) Outcome After Invasive Recurrence In Patients with Ductal Carcinoma in Situ.  4th European Breast Cancer Conference.  March 16-20, 2004.

National

 * 1) The Best Breast Cancer Papers in the World Literature, 2009-2010. American Society of Breast Diseases, New York City, NY, April 17, 2010.
 * 2) Partial Breast Radiation Workshop, American Society of Breast Surgeons, Annual Meeting, Las Vegas, NV, April 30, 2010.
 * 3) The American School of Oncology: “Great Debates In Breast Cancer. Should the Sentinel Lymph Node Biopsy be performed before or after administration of neoadjuvant chemotherapy?” (“Before” Position). Debated Ben O. Anderson, M.D., San Francisco, CA., June 19, 2009.
 * 4) Intraoperative Radiotherapy: An Acceptable Alternative to Conventional Radiotherapy. American Society of Breast Diseases Annual Meeting,  San Diego, CA.  April 11, 2008.
 * 5) Oncoplastic Approaches to Breast Conservation: Case Examples. American Society of Breast Diseases School of Oncoplastic Surgery: Essentials for Breast Surgeons.  Dallas, TX, December 9, 2007
 * 6) The American School of Oncology: Great Debates In Breast Cancer. “Con” position in favor of excision alone for good prognosis Ductal carcinoma in situ. Las Vegas, NV, October 26, 2007.
 * 7) The American School of Oncology: Great Debates In Breast Cancer. “Pro” position in favor of axillary radiotherapy as an alternative to axillary node dissection. Las Vegas, NV, October 26, 2007.
 * 8) Cost Effective Preoperative Workup and Follow-up of the Breast Cancer Patient. Louisville Breast Cancer Update.  University of Louisville.  Louisville, Kentucky.  September 15, 2007.
 * 9) Breast Cancer Risk Assessment & Prevention. Breast Cancer Awareness Seminar.  Georgia Institute of Technology Global Conference.  Atlanta, GA. September 29, 2007.
 * 10) Optimal Preoperative Work-up and Follow-up of the Breast Cancer Patient. 7th Annual Meeting of the American Society of Breast Surgeons, Baltimore, MD, May 5, 2007.
 * 11) Minimally Invasive Breast Procedure Clinic: An Innovative Way to Teach Breast Fellows Breast Ultrasound and Ultrasound-Guided Breast Procedures.  7th Annual Meeting of the American Society of Breast Surgeons, Baltimore, MD, April 9, 2006.

Local

 * 1) Annual Patient Remembrance Service. Keynote Presentation.  USC Norris Comprehensive Cancer Center.  Los Angeles, CA September 19, 2010.
 * 2) Breast Cancer: What you should know?  Keynote  Lecture.  Women of Color Breast Cancer Network.  Los Angeles, CA, September 18, 2010.
 * 3) Intraoperative Radiotherapy: Overview and Current Research. Orange Coast Breast Consortium,  Newport Beach, CA, September 17, 2010.
 * 4) Gynecology-Oncology Grand Rounds Lecture: Breast Cancer Management. USC Keck School of Medicine. Los Angeles, CA.  September 16, 2010.
 * 5) Surgical Management of Breast Cancer. Family Practice Grand Rounds. Ventura County Medical Center, Ventura County, CA. August 25, 2010.
 * 6) Breast Surgery in High Risk Patients. Citrus Valley Medical Center, Covina, CA, April 20, 2010.
 * 7) Breast Cancer Surgery in the New Millennium. Kern Medical Center, Bakersfield, CA, March 31, 2010.
 * 8) Breast Cancer Surgery in the New Millennium. Pacific Alliance Medical Center, Los Angeles, CA, March 4, 2010.
 * 9) Ten Things Your Patient Should Do Before Undergoing Breast Cancer Surgery. USC Norris Comprehensive Cancer Center CME Lecture. December 5, 2009.
 * 10) Breast Cancer Update. Torrance Memorial Hospital, Torrance, CA, September 23, 2009.
 * 11) Surgery Grand Rounds: Surgical Management of Breast Cancer, Kern Medical Center, Bakersfield, CA, July 22, 2009.
 * 12) Advancements in the Management of Breast Cancer. Bellflower Medical Center, Bellflower, CA, June 23, 2009.
 * 13) Breast Cancer in African American Women. Keynote Lecture. The Seventh Biennial Health Care Symposium.  Chapman University, Orange CA.  May 16, 2009.
 * 14) Inflammatory Breast Cancer. Keynote Lecture. National Multicultural Cancer Awareness-African American Health Forum.  Sponsored by the Los Angeles Chapter of the American College of Surgeons, April 28, 2009.
 * 15) Ten Things Your Patient Should Do Before Undergoing Breast Cancer Surgery. City Valley Medical Center, Covina, CA, April 9, 2009.
 * 16) Psychosocial Issues in Breast Cancer. Psychosocial Seminar. USC Norris Comprehensive Cancer Center, Los Angeles.  March 25, 2009.
 * 17) Triple Negative Breast Cancer. Sister’s Network Breast Cancer Support Group.  Annual Kenote.  Los Angeles, CA, October 25, 2008.
 * 18) Breast Cancer In African American Women.  The Green Foundation, Orange, CA, October 25, 2008.
 * 19) Breast Cancer Update. Torrance Memorial Medical Center, Torrance, CA, October 22, 2008.
 * 20) Breast Cancer Risk Assessment & Prevention. Nabisco Headquarters, Glendale, CA. October 17, 2007.
 * 21) Intraoperative Radiotherapy. Hoag Presbyterian Hospital Breast Cancer Symposium, Costa Mesa, CA, September 20, 2008.
 * 22) Breast Cancer Risk and Assessment. Sisters by Choice, Inc. Atlanta, GA September 13, 2008.
 * 23) Advancements in the Management of Breast Cancer. Verdugo Hills Hospital, Los Angeles, CA July 9, 2008.
 * 24) Improving Success of Breast Cancer Treatment and Survival with Clinical Trials. Women of Color Breast Cancer Support Group. Los Angeles, CA, January 12, 2008.

Abstracts

 * 1) Holmes DR, Buchanan C, Alleyne R, Nakamura SK, Silberman H, Waisman JR, Woo CS, Silverstein MJ. Nonpalpable breast carcinoma: superior survival when compared with palpable breast cancer.  Breast Cancer Research and Treatment, 76 (Suppl 2): S148, 2002.
 * 2) Buchanan C, Alleyne R, Holmes DR, Nakamura SK, Silverstein MJ. Prognosis of infiltrating lobular versus infiltrating ductal carcinoma of the breast.  Breast Cancer Research and Treatment, 76 (Suppl 2): S43, 2002.
 * 3) Alleyne R, Buchanan C, Holmes DR, Nakamura SK, Silberman H, Waisman JR, Woo CS, Silverstein MJ. The impact of immunohistochemistry on axillary lymph node positivity.  Breast Cancer Research and Treatment, 76 (Suppl 2): S130, 2002.

Chapters

 * 1) Holmes, DR. Intraoperative Radiotherapy in the Management of Early Stage Breast Cancer.  In: Breast Conservation Surgery: An Oncoplastic Approach. Chapter 8.  (MacMillan RD, McCulley SJ) 2009
 * 2) Holmes, DR. Lobular Neoplasia. In: Surgical Oncology (2nd Ed. Silberman HS, Silberman AW) 2009.
 * 3) Sheth P, Larson LH, Parisky Y, Holmes DR. Breast Ultrasonography-Performance and Clinical Applications. In: Surgical Oncology (2nd Ed. Silberman H, Silberman AW) 2009.

Peer Reviewed

 * 1) Holmes DR, Streeter OE. Commentary on: Intraoperative high-dose-rate brachytherapy—a novel technique in the surgical management of axillary recurrence [Breast J 15:140-145, 2009]. Breast Diseases: A Year Book Quarterly 21:XX-XX, 2010.
 * 2) Jeong J-W, Sin DC, Do S-H, Blanco C, Klipfel NE, Holmes DR, Hovanessian-Larsen LJ, Marmarelis VZ.  Differentiation of Cancerous Lesions in Excised Human Breast Specimens under Multiband Attenuation Profiles from ultrasonic transmission tomography. Journal of Ultrasound Medicine.  2008;27:435-451.
 * 3) Holmes DR, Baum M, Joseph DJ. The TARGIT Trial: Targeted Intraoperative Radiation Therapy Versus Conventional Post-Operative Whole Breast Radiotherapy after Breast Conserving Surgery for the Management of Early Stage Invasive Breast Cancer (A Trial Update).  Am J Surg.  2007;194(4):507-10.
 * 4) Holmes DR, Silverstein MJ. Minimally Invasive Breast Procedure Clinic:  An Innovative Way to Teach Breast Fellows Breast Ultrasound and Ultrasound-Guided Breast Procedures.  Am J Surg.  2006;192(4):439-43.
 * 5) Lee LA, Silverstein MJ, Chung CT, Sanghavi P, Macdonald HR, Epstein M, Holmes DR, Silberman H, Ye W, Lagios M. Breast Cancer Specific Mortality After Invasive Local Recurrence in Patients With Ductal Carcinoma in Situ of the Breast.  Am J Surg.  2006;192(4):416-9.
 * 6) Macdonald HR, Silverstein MJ, Ye W, Lee L, Sanghavi P, Holmes DR, Silberman H, Lagios M.  Margin width as the sole determinate of local recurrence after breast conservation in patients with ductal carcinoma in situ (DCIS) of the breast.  Am J Surg.  2006;192(4):420-2.
 * 7) Silverstein MJ, Lagios MS, Recht A, Holmes DR, et al. Image-Detected Breast Cancer: State of the Art Diagnosis and Treatment.  J Am Coll Surg. 2005;10(4):586-596.
 * 8) MacDonald HR, Silverstein MJ, Mabry H, Moorthy B, Ye W, Epstein MS, Holmes DR, Silberman H, Lagion M. Local control in ductal carcinoma in situ treated with excision alone: incremental benefit of larger margins.  American Journal of Surgery.  2005;190:521-525.
 * 9) Godfrey RS, Holmes DR, Kumar AS, Kutner SE. Sentinel lymph node biopsy at Kaiser Permanente for patients with breast cancer: TPMG's Five-year experience.  The Kaiser Permanente Journal. 2005;9(1):77-83.
 * 10) Romero L, Klein L, Holmes DR, Ye W, Soni R, Silberman H, Lagios MD, Silverstein MJ. Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast.  Am J Surg. 2004;188:371-376.

National Panel Participation

 * Interdisciplinary Tumor Board. American Society of Breast Diseases, 33rd Annual Symposium. April 2-4 2009
 * Minimally Invasive Surgery in the Interdisciplinary Setting. American Society of Breast Diseases, 33rd Annual Symposium.  April 2-4 2009
 * Interdisciplinary Tumor Board. American Society of Breast Surgeons, Annual Meeting, April 11, 2008
 * Surgical Management of Early Breast Cancer. American Society of Breast Diseases, 32 Annual Symposium, April 11, 2008.
 * Invasive Diseases: Staging and Treatment. American Society of Breast Diseases, 32 Annual Symposium, April 11, 2008.
 * Interdisciplinary Tumor Board. American Society of Breast Diseases, 32 Annual Symposium, April 11, 2008.
 * Society of Surgical Oncology, Discussant, Scientific Poster Session, March 15-18, 2007
 * Living in Abundant Wellness—Ask the Doctor. My Sister My Friend Annual Awareness Luncheon.  Lakewood, CA.  October 6, 2007.
 * Challenging Breast Imaging Cases.  Summer Seminars in Breast Imaging, Los Angeles Radiological Society, Los Angeles, CA, July 15, 2006.

Media Appearances

 * 1) FOX 11 News. July 29, 2010: http://www.myfoxla.com/dpp/health/one-day-breast-cancer-treatment-targit-20100728. News story on TARGIT Trial and Intraoperative Radiotherapy.
 * 2) MidDay Sunday. July 25, 2010.  Fox Channel 11.  30 minute interview on TARGIT Trial and Intraoperative Radiotherapy and breast cancer in general
 * 3) The Today Show Appearance, July 14, 2009: http://today.msnbc.msn.com/id/26184891/vp/31903335#31903335
 * 4) Diagnosis Live! Fox Network.  On-camera consultant. Pilot for 2009-2010 Season
 * 5) Health Zone. Show #111. Cancer. March 22, 2006.
 * 6) NBC National News Appearance. Intraoperative Radiotherapy., December 3, 2005.
 * 7) Breast Cancer Awareness. Vital Options International Radio Program.  Program 505. October 9, 2005.
 * 8) Non-chemotherapy Advancement in the Diagnosis and Treatment of Breast Cancer. Vital Options International Radio Program. Program #492. July 10, 2005.
 * 9) In Support of National Minority Cancer Awareness. Vital Options Radio Program. Program #480. April 17, 2005.

Compassionate Care
Dr. Holmes knows first-hand the fear and anxiety that most women experience during the evaluation of a breast cancer. Having supported several of his own family members through cancer diagnoses and treatments, he has a clear understanding of the surgeon's role in shaping a woman's cancer experience. As essential as it is to properly evaluate and effectively treat breast cancer, Dr. Holmes believes that it is equally important to instill in each woman the feeling that she is in safe, caring hands.

"You can be assured that I will always act with your best interest in mind." -Dennis R. Holmes, M.D.

This philosophy reflects the individualized approach that Dr. Holmes applies to each of his patients. He understands that each woman is unique emotionally and physically. He also understands that she is unique in terms of the type, size, and location of her cancer, as well as her philosophy about how her cancer should be managed. This personalized approach allows each woman to select treatments that are most suitable to her.

Improving your quality of life after breast cancer surgery
In addition to providing superior care to his patients before and during breast cancer surgery, Dr. Holmes' research focus is dedicated to developing and expanding the use of surgery and radiation therapy approaches that reduce the burden of cancer therapy and the side effects that most breast cancer patients must ensure for what is likely be a long and otherwise healthy life. With these goals in mind, Dr. Holmes serves  as the principal investigator, co-investigator, or collaborator on multiple breast cancer research trials, including clinical trials investigating axillary reverse mapping (surgery performed to prevent arm lymphedema), cryoablation (killing of tumors by freezing), and newer approaches for sentinel node biopsy, and treatment of triple negative breast cancers, among others. Dr. Holmes is also one of the world's leading authorities on intraoperative radiotherapy and continues to pioneer ground-breaking research on intraoperative radiotherapy of the breast.

Leading the Way
As a research pioneer and university professor, Dr. Holmes' accomplishments in breast cancer research have made him a sought after lecturer both nationally and internationally on innovations in breast surgery and breast radiation therapy. Dr. Holmes fines particular joy in his role as breast surgery instructor for medical students, surgical residents, and breast surgeon trainees at the University of Southern California Keck School of Medicine. Dr. Holmes is also actively involved in community outreach and to ensuring that women have the information they need to make smart breast health decisions.

Active Clinical Studies

 * 1) A Pilot Clinical Trial to Evaluate the Biological Effect of SAHA on Estrogen and Progesterone Receptor Gene Expression in Receptor Negative Invasive Breast Cancer.  Principal Investigator.  Investigator-Initiated.  California Breast Cancer Research Program Innovative Research Award..
 * 2) I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2. Co-investigator.  IRB Protocol #1B-10-3.
 * 3) The TARGIT Trial: An International Randomized Controlled Trial to Compare Targeted Intraoperative Radiotherapy with Conventional Postoperative Radiotherapy after Conservative Breast Surgery For Women With Early Stage Breast Cancer. USC Principal Investigator.  IRB Protocol #1B-04-4.
 * 4) Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma in Situ of the Breast (TARGIT-DCIS Trial): Use of Breast MRI and Mammography to Identify Candidates for IORT. Principal Investigator.  Investigator-Initiated. IRB Protocol 1B-06-9.
 * 5) Green Tea in Breast Cancer Patients. Co-investigator, (Principal Investigator: Anna Wu, Phd), IRB Protocol  HS-07-00408.
 * 6) MammaPrint® Implementation Project. Co-investigator, (Principal Investigator: Agustin Garcia, M.D.), IRB Protocol 1B-09-11.
 * 7) Imaging Findings Following IORT. Principal Investigator.  Investigator-Initiated, IRB Protocol HS-09-00571.
 * 8) Response to Neoadjuvant Chemotherapy. Co-investigator, (Principal Investigator: Agustin Garcia, M.D.), IRB Protocol 1B-09-9.
 * 9) Isolation of stem cells. Co-investigator, (Principal Investigator: Young Hong, Phd), IRB Protocol HS-09-00317
 * 10) A Pilot Clinical Trial to Evaluate the Biological Activity of 5-azacitidine on ER and PR Expression in Triple Negative Invasive Breast Cancer. Principal Investigator.  Investigator-Initiated.  IRB Protocol 1B-09-15. Funded by Celgene, Inc. IRB Protocol 1B-10-10
 * 11) EphB4 expression in Breast Cancer. Principal Investigator.  Investigator-Initiated.  IRB Protocol 1B-09-15.
 * 12) Randomized Controlled Trial evaluating the ability of Axillary Reverse Mapping to Reduce Arm Lymphedem. Principal Investigator. Investigator-Initiated. IRB Protocol 1B-09-12.
 * 13) A Phase II study evaluating the role of sentinel lymph node surgery and axillary lymph node dissection following preoperative chemotherapy in women with node positive breast cancer (T1-4, N1-2, M0) at Initial Diagnosis. Sponsored by ACOSOG. USC Principal Investigator. IRB Protocol CTSU/ACOSOG Z1071.
 * 14) Minimal Invasive Breast Surgery Feasibility Study. Principal Investigator. Investigator-Initiated. IRB Protocol 1B-09-14.
 * 15) Management of Idiopathic Granulomatous Mastitis. Principal Investigator. Investigator-Initiated. IRB Protocol 1B-09-16. (Under IRB review)
 * 16) Anastrozole as neoadjuvant therapy for breast cancer: Genomic profiling and molecular markers for treatment management. Co-investigator. (Principal Investigator: Agustin Garcia, M.D.), IRB Protocol APP-08-05104. (Under IRB review).
 * 17) Efficacy and safety of gadobutrol 1.0 molar (Gadovist®) for breast MRI. Co-investigator. (Principal Investigator: Linda Hovanessian Larsen, M.D.), IRB Protocol APP-10-01228. (Under IRB review).